Skip to main content
. 2022 Jan 21;17(1):e0262466. doi: 10.1371/journal.pone.0262466

Table 2. Serotype-specific carriage rate by vaccination status.

Serotype Vaccinated (3 doses) Unvaccinated (0 dose) p-value
N = 1810 N = 588
PCV10-types n (%) n (%)
1 1 (0.1) 1 (0.2) 0.402
4* 3 (0.2) 4 (0.7) 0.045
6B 37 (2.0) 20 (3.4) 0.061
9V/9A * 14 (0.8) 13 (2.2) 0.004
14 27 (1.5) 4 (0.9) 0.130
18C/18F/18B/18A 25 (1.4) 9 (1.5) 0.790
19F * 22 (1.2) 16 (2.7) 0.011
23F 51 (2.8) 20 (3.4) 0.468
Additional PCV-13 specific types
3 2 (0.1) 1 (0.2) 0.723
6A * 108 (6.0) 49 (8.3) 0.044
19A * 100 (5.5) 20 (3.4) 0.040
NVT serotypes
13 44 (2.4) 17 (2.9) 0.538
20 5 (0.3) 0 (0) 0.202
21 30 (1.7) 9 (1.5) 0.833
31 3 (0.2) 0 (0) 0.323
34 48 (2.7) 14 (2.4) 0.719
10A 106 (5.9) 23 (4.0) 0.069
10F/10C/33C 19 (1.1) 9 (1.5) 0.346
11A/11D * 84 (4.6) 12 (2.0) 0.005
12F/12A/44/46 12 (0.7) 5 (0.9) 0.638
15B/15C 110 (6.1) 27 (4.6) 0.178
15F/15A 24 (1.3) 8 (1.4) 0.949
16F 43 (2.4) 13 (2.2) 0.818
17F 33 (1.8) 6 (1.0) 0.181
22F/22A 11 (0.6) 4 (0.7) 0.846
23A 22 (1.2) 6 (1.0) 0.702
23B 37 (2.4) 16 (2.7) 0.332
24F/24A/24B 16 (0.9) 4 (0.7) 0.637
33F/33A/37 19 (1.1) 6 (1.0) 0.952
35A/35C/42 19 (1.1) 5 (0.9) 0.673
35B 57 (3.2) 13 (2.2) 0.240
35F/47F 4 (0.2) 1 (0.2) 0.814
38/25F/25A 13 (0.7) 1 (0.2) 0.130
6C 21(1.2) 6 (1.0) 0.780
6D 18 (1.0) 10 (1.7) 0.166
7C/7B/40 29 (1.6) 11 (1.9) 0.659
9N/9L * 9 (0.5) 23 (3.9) <0.001
2 1 (0.1) 0 (0) 0.569
8 3 (0.2) 1 (0.5) 0.146
All PCV10-types (VT) * 180 (9.9) 87 (14.8) 0.001
Non-PCV10-types (NVT)* 1194 (66.0) 351 (59.7) 0.006
Non-PCV13-types 984 (54.3) 281 (47.7) 0.450

*p-value less than 0.05.